Pharmacokinetic Interaction Between Fingolimod and Carbamazepine in Healthy Subjects
Author:
Affiliation:
1. Novartis Pharma AG; Basel Switzerland
2. Novartis Pharmaceuticals Corporation; East Hanover NJ USA
3. Novartis Healthcare Private Limited; Hyderabad India
4. Buffalo Clinical Research Center; Buffalo NY USA
Funder
Novartis Pharma AG, Basel.
Publisher
Wiley
Subject
Pharmacology (medical),Pharmaceutical Science
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1002/cpdd.459/fullpdf
Reference36 articles.
1. Fingolimod (FTY720): discovery and development of an oral drug to treat multiple sclerosis;Brinkmann;Nat Rev Drug Discov.,2010
2. Mechanism of action of oral fingolimod (FTY720) in multiple sclerosis;Chun;Clin Neuropharmacol.,2010
3. Oral fingolimod (FTY720) for relapsing multiple sclerosis;Kappos;N Engl J Med.,2006
4. Oral fingolimod or intramuscular interferon for relapsing multiple sclerosis;Cohen;N Engl J Med.,2010
5. Phase II study of oral fingolimod (FTY720) in multiple sclerosis: 3-year results;Comi;Mult Scler.,2010
Cited by 4 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Drugs Used in the Treatment of Multiple Sclerosis During COVID-19 Pandemic: A Critical Viewpoint;Current Neuropharmacology;2022-01
2. Pharmacokinetic Approach of Clinically Important Drug Interactions of Hormonal Contraceptives – A Review;Endocrine, Metabolic & Immune Disorders - Drug Targets;2021-08-26
3. Sphingosine-1-Phosphate Receptor Modulators and Oligodendroglial Cells: Beyond Immunomodulation;International Journal of Molecular Sciences;2020-10-13
4. Bioequivalence Study of 2 Capsule Formulations of Fingolimod 0.5 mg Assessing Both Parent Drug and Active Metabolite in New Zealand Healthy Subjects (Truncated Design);Clinical Pharmacology in Drug Development;2020-05-28
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3